Blood test to detect bladder cancer DNA after surgery
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study examines whether a simple blood test can detect cancer DNA (circulating tumor DNA, or ctDNA) in patients with a specific type of bladder cancer. Detecting this DNA in blood may help doctors predict how the cancer will behave and guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and can understand and sign an informed consent form
- You have been diagnosed with bladder cancer that appears to be T1 G3 (a specific stage and grade) confirmed by cystoscopy (a camera test of the bladder)
- You are scheduled to undergo TUR-B (transurethral resection of the bladder tumor—a surgical procedure to remove the tumor)
- You do not have cancer that has spread to distant parts of your body (metastases) or tumors in the upper urinary tract (ureters or kidneys) at the time of diagnosis
- You are able to follow study procedures and attend follow-up visits without major language or cognitive barriers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a simple urine test that looks for DNA changes to help find bladder or urinary tract cancer early. It is for people who have blood in their urine and are going to have surgery, to see if the test can accurately detect cancer before surgery.
This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.
This trial studies if a urine test for tumor DNA can help decide when a second surgery is needed for early stage bladder cancer. It may reduce unnecessary procedures for some patients.
This trial is testing whether a urine test for tumor DNA/RNA can help guide the decision for a second surgery in people with high-risk, non-muscle-invasive bladder cancer. It aims to see if the urine test can predict who needs the second surgery, potentially avoiding unnecessary procedures.
This study looks for specific DNA changes in bladder cancer tumors using a precise test. It aims to better understand the disease and may help guide future treatment choices.
This study is testing a new, non-invasive urine test that looks for specific DNA changes (methylation patterns) to find bladder cancer early. If you have bladder cancer or are a healthy person willing to help, you may be able to join.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.